Samsung Biologics Signs Pharmaceutical Contract Manufacturing Agreement Worth 276.8 Billion KRW
![[Image source=Yonhap News]](http://www.asiae.co.kr/news/img_view.htm?img=2022070408133836083_1656890018.jpg)
[Asia Economy Reporter Myunghwan Lee] Samsung Biologics announced on the 4th that it has signed a pharmaceutical contract manufacturing agreement worth 276.82938 billion KRW with MSD International Business.
The contract amount corresponds to 17.65% of last year's sales. The contract date is July 2, and the contract period is from July 1 to December 31, 2028.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Samsung Biologics added, "The contract amount may increase to 381.86 million USD depending on the customer's demand increase."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
